Circulating endothelial giant cells permissive for human cytomegalovirus (HCMV) are detected in disseminated HCMV infections with organ involvement
- PMID: 8394385
- PMCID: PMC294899
- DOI: 10.1172/JCI116635
Circulating endothelial giant cells permissive for human cytomegalovirus (HCMV) are detected in disseminated HCMV infections with organ involvement
Abstract
Giant cells fully permissive for human cytomegalovirus (HCMV) were found to circulate, at a variable proportion, in peripheral blood of 21 out of 25 immunocompromised patients with disseminated HCMV infection. Circulating endothelial giant cells (EGC) were identified by a specific monoclonal antibody of endothelial origin and shown to express immediate-early, early, and late viral proteins. Immunostaining patterns of different viral proteins were comparable to those detected in vitro in cultured human umbilical vein endothelial cells. EGC counts > 10 were associated with high levels (> 100) of HCMV viremia and antigenemia, as well as with an overt clinical syndrome in transplanted patients, and to an untreated long lasting organ localization in AIDS patients. On the other hand, EGC counts were < 10 during disseminated HCMV infections of both transplant recipients with no apparent organ syndrome and AIDS patients with recent organ involvement. In tissue sections from AIDS patients, infected endothelial cells were found to progressively enlarge till detaching from the small vessel wall and entering blood stream. HCMV-infected EGC represent a new systemic parameter suitable for the diagnosis of HCMV organ involvement and for the study of the pathogenesis of disseminated infections.
Similar articles
-
Diagnostic significance and clinical impact of quantitative assays for diagnosis of human cytomegalovirus infection/disease in immunocompromised patients.New Microbiol. 1998 Jul;21(3):293-308. New Microbiol. 1998. PMID: 9699213
-
Circulating cytomegalic endothelial cells are associated with high human cytomegalovirus (HCMV) load in AIDS patients with late-stage disseminated HCMV disease.J Med Virol. 1998 May;55(1):64-74. J Med Virol. 1998. PMID: 9580888
-
In vitro generation of human cytomegalovirus pp65 antigenemia, viremia, and leukoDNAemia.J Clin Invest. 1998 Jun 15;101(12):2686-92. doi: 10.1172/JCI1633. J Clin Invest. 1998. PMID: 9637702 Free PMC article.
-
Pathogenesis of human cytomegalovirus infection and cellular targets.Hum Immunol. 2004 May;65(5):381-6. doi: 10.1016/j.humimm.2004.02.009. Hum Immunol. 2004. PMID: 15172435 Review.
-
Cytomegalovirus persistence in macrophages and endothelial cells.Scand J Infect Dis Suppl. 1995;99:34-40. Scand J Infect Dis Suppl. 1995. PMID: 8668941 Review.
Cited by
-
Whole Blood versus Plasma Samples-How Does the Type of Specimen Collected for Testing Affect the Monitoring of Cytomegalovirus Viremia?Pathogens. 2022 Nov 19;11(11):1384. doi: 10.3390/pathogens11111384. Pathogens. 2022. PMID: 36422636 Free PMC article.
-
Transmission of cell-associated human cytomegalovirus isolates between various cell types using polymorphonuclear leukocytes as a vehicle.Med Microbiol Immunol. 2021 Aug;210(4):197-209. doi: 10.1007/s00430-021-00713-6. Epub 2021 Jun 6. Med Microbiol Immunol. 2021. PMID: 34091753 Free PMC article.
-
Profiling the Blood Compartment of Hematopoietic Stem Cell Transplant Patients During Human Cytomegalovirus Reactivation.Front Cell Infect Microbiol. 2021 Jan 8;10:607470. doi: 10.3389/fcimb.2020.607470. eCollection 2020. Front Cell Infect Microbiol. 2021. PMID: 33489936 Free PMC article.
-
Human Cytomegalovirus Cell Tropism and Host Cell Receptors.Vaccines (Basel). 2019 Jul 22;7(3):70. doi: 10.3390/vaccines7030070. Vaccines (Basel). 2019. PMID: 31336680 Free PMC article. Review.
-
Circulating endothelial progenitor cells and endothelial cells in moyamoya disease.Brain Behav. 2018 Sep;8(9):e01035. doi: 10.1002/brb3.1035. Epub 2018 Aug 23. Brain Behav. 2018. PMID: 30141248 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical